Saturday, August 28, 2010

Green Cross receives approval for Peramivir in South Korea

http://www.businesswire.com/news/home/20100816005534/en/BioCryst%E2%80%99s-Partner-Green-Cross-Receives-Marketing-Manufacturing

Peramivir has now received regulatory approval in both Japan and South Korea. In the US, Peramivir is in phase III clinical trials

No comments:

Post a Comment